Literature DB >> 2339905

Effects of murine recombinant interleukin 1 on synovial joints in mice: measurement of patellar cartilage metabolism and joint inflammation.

A A van de Loo1, W B van den Berg.   

Abstract

Murine recombinant interleukin 1 was injected intra-articularly into mice. It induced a clear effect on patellar cartilage within 24 hours. A low dose of interleukin 1 (1 ng) elicited a significant reduction in [35S]sulphate incorporation (50%) into proteoglycans and an accelerated breakdown (twofold) of 35S prelabelled proteoglycan. Proteoglycan breakdown returned to normal rates (approximately 10%/day) 48 hours after a single interleukin 1 injection. Recovery of proteoglycan synthesis was delayed by up to 72 hours, however, which implies that repair of the depleted cartilage matrix is retarded. Interleukin 1 induced only minor joint inflammation, too slight to be held responsible for the strong suppression of proteoglycan synthesis. Vehement joint inflammation was found after repeated interleukin 1 injections. The plasma extravasation and massive infiltration and exudation of leucocytes, predominantly polymorphonuclear leucocytes, were not a mere summation of single interleukin 1 effects, but point to interleukin 1 induced local hypersensitivity. The cartilage matrices of patella and femur were heavily depleted. Measurement of the extent of loss of 35S prelabelled proteoglycan and the prolonged inhibition of [35S]sulphate incorporation indicate that both inhibition of proteoglycan synthesis and enhanced loss of proteoglycan contributed substantially to this depletion.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2339905      PMCID: PMC1004046          DOI: 10.1136/ard.49.4.238

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  52 in total

1.  Interleukin 1 increases the binding of human B and T lymphocytes to endothelial cell monolayers.

Authors:  D E Cavender; D O Haskard; B Joseph; M Ziff
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

2.  Interleukin 1: a common endogenous mediator of inflammation and the local Shwartzman reaction.

Authors:  G Beck; G S Habicht; J L Benach; F Miller
Journal:  J Immunol       Date:  1986-04-15       Impact factor: 5.422

3.  Release of interleukin-1 from human synovial tissue in vitro.

Authors:  D D Wood; E J Ihrie; D Hamerman
Journal:  Arthritis Rheum       Date:  1985-08

4.  Effects of immune complexes on production by human monocytes of interleukin 1 or an interleukin 1 inhibitor.

Authors:  W P Arend; F G Joslin; R J Massoni
Journal:  J Immunol       Date:  1985-06       Impact factor: 5.422

5.  In vivo inflammatory activity of epidermal cell-derived thymocyte activating factor and recombinant interleukin 1 in the mouse.

Authors:  R D Granstein; R Margolis; S B Mizel; D N Sauder
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

6.  Cytokines and the chronic inflammation of rheumatic disease. I. The presence of interleukin-1 in synovial fluids.

Authors:  A M Nouri; G S Panayi; S M Goodman
Journal:  Clin Exp Immunol       Date:  1984-02       Impact factor: 4.330

7.  Articular cartilage cultured with catabolin (pig interleukin 1) synthesizes a decreased number of normal proteoglycan molecules.

Authors:  J A Tyler
Journal:  Biochem J       Date:  1985-05-01       Impact factor: 3.857

8.  Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines.

Authors:  M P Bevilacqua; J S Pober; M E Wheeler; R S Cotran; M A Gimbrone
Journal:  J Clin Invest       Date:  1985-11       Impact factor: 14.808

9.  Studies into the influence of carrageenan-induced inflammation on articular cartilage degradation using implantation into air pouches.

Authors:  A D Sedgwick; A R Moore; A Y Al-Duaij; J C Edwards; D A Willoughby
Journal:  Br J Exp Pathol       Date:  1985-08

10.  Chondrocyte-mediated depletion of articular cartilage proteoglycans in vitro.

Authors:  J A Tyler
Journal:  Biochem J       Date:  1985-01-15       Impact factor: 3.857

View more
  41 in total

1.  Cytokines and cellular interactions in inflammatory synovitis.

Authors:  W P Arend
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

2.  Cloricromene, a coumarine derivative, protects against collagen-induced arthritis in Lewis rats.

Authors:  S Cuzzocrea; E Mazzon; C Bevilaqua; G Costantino; D Britti; G Mazzullo; A De Sarro; A P Caputi
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

Review 3.  Articular cartilage destruction in experimental inflammatory arthritis: insulin-like growth factor-1 regulation of proteoglycan metabolism in chondrocytes.

Authors:  P J Verschure; C J Van Noorden; J Van Marle; W B Van den Berg
Journal:  Histochem J       Date:  1996-12

4.  Hydrolysable tannin-rich fraction from Terminalia chebula Retz. fruits ameliorates collagen-induced arthritis in BALB/c mice.

Authors:  Sanmuga Priya Ekambaram; Senthamil Selvan Perumal; Thamizharasi Erusappan; Aswini Srinivasan
Journal:  Inflammopharmacology       Date:  2019-08-19       Impact factor: 4.473

5.  Protection from interleukin 1 induced destruction of articular cartilage by transforming growth factor beta: studies in anatomically intact cartilage in vitro and in vivo.

Authors:  H M van Beuningen; P M van der Kraan; O J Arntz; W B van den Berg
Journal:  Ann Rheum Dis       Date:  1993-03       Impact factor: 19.103

6.  Multiple interleukin-1beta-converting enzymes contribute to inflammatory arthritis.

Authors:  Christian Stehlik
Journal:  Arthritis Rheum       Date:  2009-12

7.  Amelioration of established murine collagen-induced arthritis with anti-IL-1 treatment.

Authors:  W B van den Berg; L A Joosten; M Helsen; F A van de Loo
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

8.  Local interleukin-1-driven joint pathology is dependent on toll-like receptor 4 activation.

Authors:  Shahla Abdollahi-Roodsaz; Leo A B Joosten; Marije I Koenders; Ben T van den Brand; Fons A J van de Loo; Wim B van den Berg
Journal:  Am J Pathol       Date:  2009-10-15       Impact factor: 4.307

9.  Modulation of cartilage destruction in murine arthritis with anti-IL-1 antibodies.

Authors:  F A van de Loo; O J Arntz; I G Otterness; W B van den Berg
Journal:  Agents Actions       Date:  1993

10.  Insulin-like growth factor I accelerates recovery of articular cartilage proteoglycan synthesis in culture after inhibition by interleukin 1.

Authors:  J Neidel; M Schulze; L Sova
Journal:  Arch Orthop Trauma Surg       Date:  1994       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.